Silverarc Capital Management, LLC Chemo Centryx, Inc. Put Options Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$18.38 - $40.5 $2.56 Million - $5.64 Million
-139,200 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$13.18 - $19.83 $516,656 - $777,335
39,200 Added 39.2%
139,200 $2.38 Million
Q2 2021

Aug 16, 2021
BUY
$9.59 - $50.88 $959,000 - $5.09 Million
100,000 New
100,000 $1.34 Million

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email